Search

Kisqali Tablets: Updated Storage Conditions and Shelf Life

Novartis Pharma GmbH has updated the storage conditions and shelf life for Kisqali 200 mg film-coated tablets. The medicine no longer requires refrigeration and now has an authorized shelf life of 2 years. This information letter was issued by the BfArM.

Digimerck Tablets Quality Defect: Degradation Products May Exceed Limit

The German Federal Institute for Drugs and Medical Devices (BfArM) issued a Direct Healthcare Professional Communication regarding Digimerck 0.07 mg tablets. A quality defect has been identified where degradation products may slightly exceed the specification limit by the end of the product's shelf life. Distribution was discontinued in 2022.

Tegretal Suspension Use Restricted in Newborns

The German Federal Institute for Drugs and Medical Devices (BfArM) has issued a direct healthcare professional communication restricting the use of Tegretal Suspension (carbamazepine) in newborns due to high propylene glycol content. This restriction is to prevent serious side effects in infants.

Melphalan AqVida: Risk of Overdose Due to Higher Concentration

The German Federal Institute for Drugs and Medical Devices (BfArM) issued a communication regarding Melphalan AqVida RTD 90 mg/ml, a new formulation with an 18-fold higher concentration than existing melphalan products. This increased concentration poses a potential risk of overdose for patients.

EU Official Journal L Series Daily View - March 13, 2026

The EU Official Journal L series for March 13, 2026, includes new regulations and decisions. Notably, a Commission Implementing Regulation registers the geographical indication 'Kilichi du Niger' (PGI), and a Council Decision addresses the scheduling of substances under international drug conventions.

CISA Adds Two Exploited Vulnerabilities to KEV Catalog

CISA has added two new vulnerabilities, CVE-2026-3909 and CVE-2026-3910, to its Known Exploited Vulnerabilities (KEV) Catalog due to evidence of active exploitation. Federal Civilian Executive Branch (FCEB) agencies are required to remediate these vulnerabilities per Binding Operational Directive (BOD) 22-01.

NY Health Urges Colorectal Cancer Screening for Adults Under 50

The New York State Department of Health is urging adults aged 45 and older to undergo colorectal cancer screening, as it is now a leading cause of cancer death for those under 50. The department highlights that screening can prevent or detect the cancer early, and aims to improve current screening rates.

AI Security and Cybersecurity Summit for Enterprises Registration Open

The Office of the Privacy Commissioner for Personal Data (PCPD) and HKIRC are co-organising an AI Security and Cybersecurity Summit for Enterprises on March 31, 2026. Registration is now open for organizations to address AI security and cybersecurity risks. The event aims to raise awareness and readiness among businesses, including SMEs.

Privacy Commissioner Reports 2025 Work and Data Security Incidents

The Office of the Privacy Commissioner for Personal Data (PCPD) reported on its 2025 activities, including a 23% increase in complaints and a 21% rise in data breach notifications. The PCPD also intervened in three data security incidents and conducted 435 compliance checks.

Privacy Commissioner Warns of Construction Worker Recruitment Fraud

The Hong Kong Privacy Commissioner's Office issued a warning regarding fraudulent recruitment advertisements targeting construction workers. The office received 42 complaints in two weeks involving scams that requested sensitive personal data, including construction site "Three Essentials." The PCPD urges vigilance and provides guidance on safeguarding personal data during job applications.